Skip to content

Tozaro is developing a novel suite of reagents to support development and manufacture of viral vectors in cell and gene therapy.  We see viral vectors through a different lens that allows us to approach common applications such as quantification of viral titer or capture chromatography in a completely different way.  We believe the industry needs better tools to help realize the potential of cell and gene therapy.

The smart polymer difference

Good process design is a function of reagent selection.  Where reagent choice is restricted or where the selected reagent performance is a compromise, process efficiency is reduced both in terms of yield and quality.  Tozaro’s unique reagent design and build is ideal for tackling difficult bioprocessing challenges.  We not only create reagents which recognize and bind chosen epitopes on target molecules, we also tailor the reagent chemistry to your process to deliver the most impactful performance. Our reagents are scalable, so we can support our partners from development through to on market delivery.

Novel solutions for improving viral vector manufacture

New to smart polymers?

If you are not familiar with smart polymers, we have you covered. Take a look at our introductory guide to learn how Tozaro reagents are designed and developed to deliver new possibilities for the manufacture of cell and gene therapies.

Stay up to date

1463

Research

Novel synthetic affinity reagents for lentivirus analytics and capture…

Learn more
1433

NEWS

MIP Discovery rebrands as Tozaro as it completes transition…

Learn more
401

RESEARCH

Developing new tools for rapid quantification of viral vectors…

Learn more
406

NEWS

Tozaro closes £7M Series A financing to drive commercialization…

Learn more
408

NEWS

Tozaro (formally MIP Discovery) secures significant funding to support…

Learn more